Abstract | BACKGROUND AND PURPOSE: METHODS: ICH was induced by injecting autologous blood into 252 male C57BL/6 and Rag1-/- mice. One hour later, ICH mice were randomly assigned to receive an intraperitoneal injection of vehicle, PD-L1, or anti-PD-L1 antibody. Neurological function was assessed along with brain edema, brain infiltration of immune cells, blood-brain barrier integrity, neuron death, and mTOR ( mammalian target of rapamycin) pathway products. RESULTS: PD-L1 significantly attenuated neurological deficits, reduced brain edema, and decreased hemorrhage volume in ICH mice. PD-L1 specifically downsized the number of brain-infiltrating CD4+ T cells and the percentages of Th1 and Th17 cells but increased the percentages of Th2 and regulatory T cells. In the PD-L1-treated group, we observed an amelioration of the inflammatory milieu, decreased cell death, and enhanced blood-brain barrier integrity. PD-L1 also inhibited the mTOR pathway. The administration of anti-PD-L1 antibody produced the opposite effects to those of PD-L1 in ICH mice. CONCLUSIONS: PD-L1 provided protection from the damaging consequences of ICH.
|
Authors | Ranran Han, Jiaying Luo, Yanchao Shi, Yang Yao, Junwei Hao |
Journal | Stroke
(Stroke)
Vol. 48
Issue 8
Pg. 2255-2262
(08 2017)
ISSN: 1524-4628 [Electronic] United States |
PMID | 28706113
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017 American Heart Association, Inc. |
Chemical References |
- B7-H1 Antigen
- Cd274 protein, mouse
- Neuroprotective Agents
|
Topics |
- Animals
- B7-H1 Antigen
(administration & dosage)
- Blood-Brain Barrier
(drug effects, immunology, pathology)
- Brain Injuries
(immunology, pathology, prevention & control)
- Cerebral Hemorrhage
(immunology, pathology, prevention & control)
- Disease Models, Animal
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Neuroprotective Agents
(administration & dosage)
- T-Lymphocytes, Regulatory
(drug effects, immunology)
|